Close Menu

NEW YORK (GenomeWeb) – Epic Sciences announced today that its San Diego laboratory has received accreditation from the College of American Pathologists.

Epic markets a platform it calls "no cell left behind," which isolates circulating tumor cells in an unbiased manner, allowing downstream analyses of single CTCs using genomic, proteomic, and morphologic approaches.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The US Patent and Trademark Office is opening another interference proceeding in the CRISPR patent fight.

The Japan News writes that Japan needs to seize the opportunity to ensure that a wide number of people benefit from personalized cancer treatments.

There's increasing genetic evidence that a number of ancient hominins may have contributed to the human gene pool, according to Discover's The Crux blog.

In Cell this week: messenger RNA expression and translation, RNA localization atlas, and more.